Skip to content
OpenCapital
Get started

InfuSystem Holdings INFU Unamortized Debt Issuance Expense Noncurrent

Other financials

Income statement

See full
Revenue$33.7M-3.0%
Gross profit$19.7M+2.7%
Operating income$1.6M+157%
Net income$1.0M+481%
EPS (diluted)$0.05+600%

Balance sheet

See full
Cash & equivalents$2.1M+39.8%
Total debt$24.1M-30.4%
Total equity$58.7M+6.5%
Total assets$98.7M-5.4%

Cash flow

See full
Operating cash flow$970.0K-45.5%
CapEx$157.0K+19.8%
Free cash flow$813.0K-50.7%

Valuation

See full
Market cap$205.05M+51.3%
Enterprise value$227.04M+36.2%
P/E25.9×-0.8×
P/S1.4×+0.5×

Profitability

See full
Gross margin56.7%+3.6pp
Operating margin9.1%+3.0pp
Net margin5.6%+3.2pp
FCF margin16.2%+1.0pp

Returns & leverage

See full
Return on equity13.9%+8.0pp
Debt / equity0.4×-0.2×
Current ratio2.1×-0.1×

Where this comes from

Reported directly by InfuSystem Holdings in its filing.

Tagged under the XBRL concept infu:UnamortizedDebtIssuanceExpenseNoncurrent.

The official record: InfuSystem Holdings’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about InfuSystem Holdings's unamortized debt issuance expense noncurrent.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is InfuSystem Holdings's unamortized debt issuance expense noncurrent?
InfuSystem Holdings (INFU) reported unamortized debt issuance expense noncurrent of $354K in Q1 2026.
How has InfuSystem Holdings's unamortized debt issuance expense noncurrent changed year-over-year?
InfuSystem Holdings's unamortized debt issuance expense noncurrent increased by 46.9% year-over-year, from $241K to $354K.
What is the long-term trend for InfuSystem Holdings's unamortized debt issuance expense noncurrent?
Over 5 years (2020 to 2025), InfuSystem Holdings's unamortized debt issuance expense noncurrent has grown at a 50.2% compound annual growth rate (CAGR), from $49K to $375K.